Airways Inflammation Research Group

Members of the Airways Inflammation Research Group.  From left to right:  Dr. Frances Green, Dr. Robert Newton, Dr. Mark Giembycz, Dr. David Proud, Dr. Brent Winston, Dr. Margaret Kelly, Dr. Richard Leigh.  Not pictured: Dr. Bob Cowie, Dr. Stephen Field, Dr. Matthias Amrein, Dr. Alain Tremblay.

 

 

The Airways Inflammation Group at the University of Calgary in the Snyder Institute for Chronic Diseases is involved in numerous research areas targeting aspects of Asthma and COPD for which current therapies are less than ideal. The group is well positioned to study these complex diseases from a number of different perspectives, including studies of inflammatory mechanisms, surfactant function, airway remodeling, and epithelial cell biology, and can test pharmacological interventions in both pre-clinical and clinical settings. This research has been facilitated by the recent opening of a new ~1500 square foot "state-of-the-art" dedicated clinical research suite that is unique in Canada. The group is made up of basic and clinician scientists who are well published and recognized worldwide in their areas of expertise. The collaborative atmosphere within the group promotes a team effort to elucidating the underlying mechanisms of these diseases and finding better therapeutics for combating these ailments.